Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISAL 2019 | Clonal hematopoiesis of indeterminate potential (CHIP): genes, disease predisposition & potential

Siddhartha Jaiswal • 25 Feb 2019
ISAL 2019
Acute Myeloid Leukemia General Leukemia Myelodysplastic Syndromes

Siddhartha Jaiswal, MD, PhD, of Stanford University, Stanford, CA, discusses the interesting new field of clonal hematopoiesis of indeterminate potential (CHIP) and its role in leukemogenesis. Dr Jaiswal covers who this affects, what genes are most commonly mutated in the process, its effect on disease predisposition, and the potential to target it in the future. This interview took place at the International Symposium on Acute Leukemias (ISAL) 2019, held in Munich, Germany.

More from Siddhartha Jaiswal

2:02
The impact of CHIP in Alzheimer’s disease risk
Siddhartha Jaiswal • 12 Dec 2021
1:13
Investigating the effect of CHIP mutations in microglial function and Alzheimer’s disease
Siddhartha Jaiswal • 12 Dec 2021
4:38
CHIP is robustly associated with protection from Alzheimer’s disease
Siddhartha Jaiswal • 10 Dec 2021
1:11
Jaiswal lab research and updates: mutations and age-related disease
Siddhartha Jaiswal • 25 Feb 2019

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
The content of VJHemOnc is intended for healthcare professionals